Elucidating loss‐of‐function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19930 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Jiasheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medic…. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Alleles, Loss of Function Mutation, Anemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Shanghai "Rising Stars of Medical Talents" Youth Development Program, the Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics, the Key Discipline Group of Pudong New Area Health Commission.
Abstract (Originalsprache)
HIF‐2α, encoded by EPAS1 , plays a dominant role in regulating erythropoietin (EPO) production, maintaining the dynamic balance of erythropoiesis. Gain‐of‐function mutations in EPAS1 cause erythrocytosis. However, anaemia caused by EPAS1 loss‐of‐function mutations has been confined to only one case report, and the underlying mechanism remains unclear. Herein, the reanalysis of high‐throughput sequencing data from 311 patients with anaemia identified three monoallelic EPAS1 variants from three unrelated families in a paediatric anaemia cohort. The probands showed highly consistent clinical phenotypes with normocytic and normochromic anaemia, reticulocytopenia and relative deficiency of serum EPO, characterised as congenital hypoplastic anaemia. In vitro studies suggested that defects in steady‐state protein abundance, nuclear localisation and binding with co‐activator in EPAS1 variants lead to impaired EPO transcriptional activation. Therefore, loss‐of‐function mutations in EPAS1 can cause erythroid hypoplasia in an EPO‐dependent manner. This study identified a new causative gene for congenital hypoplastic anaemia and clarified the molecular aetiology of loss‐of‐function EPAS1 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Jiasheng Zhang, Jin Sun, Tingting Yu
Förderung
- Shanghai "Rising Stars of Medical Talents" Youth Development Program
- the Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics
- the Key Discipline Group of Pudong New Area Health Commission
Zitieren
APA
Zhang, J., Sun, J., Huai, W., Tang, J., Chen, J., Yao, R., & Yu, T. (2025). Elucidating loss‐of‐function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort. British Journal of Haematology. https://doi.org/10.1111/bjh.19930
Vancouver
Zhang J, Sun J, Huai W, Tang J, Chen J, Yao R, et al. Elucidating loss‐of‐function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort. British Journal of Haematology. 2025. doi:10.1111/bjh.19930
BibTeX
@article{Zhang2025,
author = {Zhang, Jiasheng and Sun, Jin and Huai, Wan and Tang, Jie and Chen, Jing and Yao, Ruen and Yu, Tingting},
title = {Elucidating loss‐of‐function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19930}
}
EUVIMED